Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.27NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2113.71Japan
AY.4.2.4 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.2.4 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.2.4 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.4.2.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.4 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.161EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.161NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.161NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.161NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.161NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.58NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.58NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.58NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.75EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.75NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.75NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.75NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.411EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.411NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.411NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.411NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.411NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.217EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.217NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.217NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.217NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.217NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.35NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.35NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.35NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.17 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.17 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.17 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.17 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.41NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.41NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.41NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.527EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.527NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.527NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.527NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used